Acquiring Company
Merit Medical Systems Inc
Acquired Company
BioLife
Description
Merit Medical Systems Inc has completed the acquisition of hemostasis products, StatSeal and WoundSeal, from BioLife for $120 million in cash. This acquisition is expected to enhance Merit Medical's revenue by $10 million to $11 million. However, it might slightly impact earnings per share in the fiscal year 2025. This strategic move reflects Merit Medical's commitment to strengthening its product portfolio.
Quick answer
Merit Medical Systems Inc is acquiring BioLife, announced May 21, 2025. Merit Medical Systems Inc is based in South Jordan, Utah, United States.
- How much did Merit Medical Systems Inc pay for BioLife?
- The deal value was not disclosed.
- What does Merit Medical Systems Inc do?
- Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical..
- Where are Merit Medical Systems Inc and BioLife based?
- Merit Medical Systems Inc is based in South Jordan, Utah, United States. BioLife is based in Sarasota, Florida, United States.
- Who are the decision-makers at Merit Medical Systems Inc?
- Fundz holds 1 contact at Merit Medical Systems Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Teleflex finalizes acquisition of Biotronik's business (July 2, 2025)
- Esteve Pharmaceuticals acquires Caprelsa® from Sanofi (July 1, 2025)
- Concentra to acquire Elevation Oncology, shut it down (June 20, 2025)
- AbbVie to acquire Cerevel Therapeutics for $45 per share (May 28, 2025)
- AbbVie to acquire Cerevel for $45 per share (April 15, 2025)
- Organon acquires Tofidence biosimilar rights (April 14, 2025)
Who to call at Merit Medical Systems Inc, and when
When Merit Medical Systems Inc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Merit Medical Systems Inc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Merit Medical Systems Inc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Merit Medical Systems Inc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Merit Medical Systems Inc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BioLife?
BioLife was acquired by Merit Medical Systems Inc, based in South Jordan. The deal was reported on May 21, 2025. Merit Medical Systems, Inc. Merit Medical Systems Inc is publicly traded (MMSI) and operates in Manufacturing.
When did Merit Medical Systems Inc acquire BioLife?
Merit Medical Systems Inc's acquisition of BioLife was reported on May 21, 2025. Merit Medical Systems Inc has completed the acquisition of hemostasis products, StatSeal and WoundSeal, from BioLife for $120 million in cash. This acquisition is expected to enhance Merit Medical's revenue by $10 million to $11 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BioLife do?
BioLife is a company specializing in products for hemostasis and wound care. The firm offers a range of innovative solutions aimed at improving patient recovery and outcomes in various clinical settings. It is privately held, operating in Biotechnology, and is based in Sarasota.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.